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Abstract Recent evidence suggests that serine/threonine phos-
phorylation and internalization of L2-adrenergic receptors play
critical roles in signalling to the mitogen-activated protein kinase
cascade. To investigate whether this represents a general
mechanism employed by G protein-coupled receptors, we studied
the requirement of these processes in the activation of mitogen-
activated protein kinase by GKq-coupled bradykinin B2 recep-
tors. Mutant B2 receptors impaired in receptor phosphorylation
and internalization are fully capable to activate mitogen-
activated protein kinase. Bradykinin-induced long-term effects
on mitogenic signalling monitored by measuring the transcrip-
tional activity of Elk1 were identical in cells expressing the wild-
type or mutant B2 receptors. Therefore, G protein-coupled
bradykinin receptors activate the mitogen-activated protein
kinase pathway independently of receptor phosphorylation and
internalization.
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1. Introduction
G protein-coupled receptors (GPCRs) are integral mem-
brane proteins involved in the transmission of signals from
a variety of extracellular ligands to the cytoplasm. Through
heterotrimeric G proteins, they activate e¡ector enzymes such
as adenylyl cyclases, phospholipases or ion channels leading
to changes in the level of second messengers and diverse cel-
lular responses [1]. Activation of several GPCRs has been
shown to elicit growth-promoting e¡ects including stimulation
of mitogenic signalling pathways, regulation of transcription,
induction of DNA synthesis and cell proliferation. In addi-
tion, naturally occurring mutants of GPCRs and G proteins
can induce cellular transformation when overexpressed in cul-
tured ¢broblasts [2,3].
The molecular mechanisms underlying GPCR-induced mi-
togenic signal transmission have been studied to some extent.
Several reports indicate that many GPCRs can activate the
Ras/mitogen-activated protein (MAP) kinase pathway, which
is su⁄cient and necessary for the control of proliferation in
di¡erent cell systems [2]. Translocation of the Grb2/Sos com-
plex in the vicinity of membrane-associated Ras represents a
common mechanism by which di¡erent GPCRs lead to Ras
and MAP kinase activation [4]. This translocation is accom-
plished by activation of protein tyrosine kinases, such as Src
family kinases, Bruton’s tyrosine kinase, Pyk2, epidermal
growth factor (EGF) or platelet-derived growth factor recep-
tor kinases, which in turn lead to phosphorylation of the
adaptor protein Shc and its association with the Grb2/Sos
complex or by direct binding of Grb2 to tyrosine-phosphoryl-
ated EGF receptor or Pyk2 [4^7]. Mechanisms by which
GPCRs activate protein tyrosine kinases appear to be di¡er-
ent. GKi-coupled receptors preferentially utilize a GLQ-de-
pendent route via PI3 kinase Q [8], whereas GKq-coupled re-
ceptors employ protein kinase C and/or calcium signals to
activate protein tyrosine kinases and the MAP kinase path-
way [4,7,9].
Recent reports have indicated that also serine/threonine
phosphorylation and internalization of GPCRs might be in-
volved in the modulation of these signalling pathways thus
a¡ecting the activation of MAP kinase. For example, an in-
volvement of L-arrestin/dynamin-dependent receptor seques-
tration was reported to be important for the association
with Src and the activation of MAP kinase by the GKs-
coupled L2-adrenergic receptor [10^12]. In addition, protein
kinase A-mediated L2-adrenergic receptor phosphorylation,
formerly thought to be mainly responsible for heterologous
receptor desensitization [13], has been shown to lead to a
switch in G protein-coupling from Gs to Gi which permits
signalling to the MAP kinase module in a GLQ-dependent
manner [14]. However, a role of receptor phosphorylation
and internalization in linking other prototypic GPCRs with
MAP kinase activation has not yet been studied.
Therefore, we have investigated whether phosphorylation
and/or internalization of the GKq-coupled bradykinin B2 re-
ceptor (B2R) is important for agonist-induced MAP kinase
activation. B2Rs have been implicated in the regulation of
blood pressure and cell proliferation in response to kinin pep-
tides [15^18]. They have been shown to activate the MAP
kinase cascade via protein kinase C and/or calcium-dependent
pathways, involving protein tyrosine kinases Pyk2, Src and
EGF receptor [6,7,19,20]. Recently, we have demonstrated
that B2R internalization requires phosphorylation on three
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serines and two threonine residues in the carboxy-terminal tail
[21]. In this report, we analyzed the ability of the wild-type
B2R or phosphorylation- and internalization-de¢cient recep-
tor mutants to activate MAP kinase and regulate transcrip-
tion in HEK 293T cells. Our data indicate that bradykinin-
induced activation of MAP kinase and Elk-mediated tran-
scription are not dependent on serine/threonine phosphoryla-
tion and phosphorylation-mediated internalization of B2R.
2. Materials and methods
2.1. Materials
Rainbow protein marker, [Q-32P]ATP (s 4000 Ci/mmol) and
[32P]H3PO4 (285 Ci/mg P) were from Amersham, bradykinin was
from Bachem, aprotinin (Trasylol) was from Bayer, Bradford protein
assay kit was from Bio-Rad, leupeptin was from Boehringer Mann-
heim, Pefabloc was from FLUKA, Lipofectamine and protein ladder
markers (10^200 kDa) were from Life Technologies, ATP, bovine
serum albumin (BSA), Dulbecco’s modi¢ed Eagle’s medium
(DMEM), fetal bovine serum (FBS) and myelin basic protein
(MBP) were from SIGMA and protein A-agarose was from
Zymed. All other chemicals of analytical grade were from Merck or
SIGMA.
2.2. Plasmids
Human B2R was cloned as previously described and subcloned into
the mammalian expression vector pcDNA3 [22]. Mutants were gen-
erated using the Transformer site-directed mutagenesis kit from Clon-
tech. In B2vST mutant, serines at positions 339, 346 and 348 as well
as threonine at 342 and 345 were substituted by alanine and in
B2tI334, a stop codon was introduced after isoleucine 334 [21]. He-
maglutinin (HA)-tagged extracellular-regulated kinase 2 (ERK2) was
kindly provided by C. Marshall, Institute of Cancer Research (Lon-
don, UK).
2.3. Cell Culture and transfection
Human embryonic kidney cells HEK 293T were grown on six well
plates to about 50% con£uence in DMEM containing 10% FBS.
Transfections were done in serum-free medium with 1^2 Wg/well of
the indicated cDNAs by the Lipofectamine method according to the
supplier’s manual. Cells were kept in a humidi¢ed 5% CO2, 95% air
atmosphere at 37‡C. About 24 h after transfection, cells were serum-
starved in DMEM containing 0.3% BSA for another 24 h and used
for experiments.
2.4. Immunoprecipitation of HA-ERK2 and in vitro kinase reaction
Transfected and serum-starved cells were stimulated for 0.5^60 min
with di¡erent concentrations of bradykinin at 37‡C. After two washes
with PBS, cells were scraped into 0.5 ml of ice-cold lysis bu¡er con-
taining 50 mM HEPES, pH 7.2, 150 mM NaCl, 1 mM EDTA, 20 mM
NaF, 2 mM sodium orthovanadate, 1% (w/v) Triton X-100, 10% (w/v)
glycerol and protease inhibitors (1 mM Pefabloc, 10 Wg/ml leupeptin
and 1% Trasylol). Following 45 min at 4‡C with gentle rocking, a
soluble fraction was prepared by centrifugation at 4‡C for 15 min at
13 000 rpm. Equal amounts of lysates (about 200 Wg protein, meas-
ured by the Bradford assay) was subjected to immunoprecipitation
with 5 Wl of a polyclonal antiserum against the HA-tag (provided
by S. Ekman, Ludwig Institute for Cancer Research, Uppsala, Swe-
den). Incubations were carried out with 35 Wl protein A-agarose slurry
for 3 h at 4‡C. Resultant precipitates were washed three times with
lysis bu¡er (see above) followed by two washes with kinase bu¡er
containing 10 mM Tris, pH 7.5, 10 mM MgCl2. Kinase reactions
were started by addition of 30 Wl kinase bu¡er including 200 WM
ATP, 1 WCi [Q-32P]ATP and 10 Wg MBP. Reactions were performed
for 20 min at room temperature and stopped by addition of 30 Wl SDS
sample bu¡er and heating for 2 min at 98‡C. Proteins were separated
by 12% SDS polyacrylamide gel electrophoresis (SDS-PAGE) and gels
were cut above the 30 kDa marker band. Upper parts were trans-
ferred onto nitrocellulose membranes (Schleicher and Schuell) using a
semi-dry unit (Bio-Rad) and probed with 0.5 Wg/ml anti-ERK2 anti-
bodies (Santa Cruz) in 5% BSA/TBS to check equal immunoprecipi-
tation of HA-ERK2 in all samples. Lower parts were stained with
0.2% Coomassie brilliant blue R250 in 10% acetic acid, 12.5% iso-
propanol to monitor the amounts of MBP. Substrate phosphorylation
was analyzed using a Phosphoimager (Fuji, BAS2000).
2.5. Receptor phosphorylation
Phosphorylation analysis of B2R and its mutants in 293T cells was
done as previously described [23]. For immunoprecipitation of radio-
labelled receptors, a polyclonal anti-peptide antibody against the
C-terminal domain was used [23]. For the B2tI334 mutant lacking
this epitope, a mixture of polyclonal antibodies against GST fusion
proteins of the N-terminal and of the third extracellular domain was
applied [24]. Precipitation of receptor protein was followed by parallel
[35S] labelling experiments.
2.6. Inositol phosphate generation and receptor internalization
The measurement of inositol phosphate generation triggered by
kinin receptors and the analysis of receptor internalization were
done as previously detailed [22].
2.7. Elk luciferase assay
The luciferase assays were done using pFA-Elk1 and pFR-Luc re-
porter plasmids of the PathDetect Reporting System (Stratagene) and
the Luciferase Assay System kit (Promega). HEK 293T cells grown on
12 well plates to 50% con£uence were transfected using the lipofect-
amine method, with the following amounts of cDNA per well: 200 ng
receptor, 100 ng L-galactosidase, 50 ng luciferase (pFR-Luc) and 50 ng
Elk1 (pFA-Elk1). After 6 h incubation, 10% FBS was added and cells
were allowed to regenerate for 12 h. Thereafter, cells were serum-
starved for 24 h, stimulated with 1 WM bradykinin for 12 h and lysed
thereafter in 150 Wl/well of 1% Triton X-100, 10% glycerol, 25 mM
Tris phosphate pH 7.8, 2 mM dithiothreitol, 2 mM trans-1,2-diami-
nocyclohexane-N,N,N’,N’ tetra acetic acid. Luciferase activity in cell
lysates was measured using the Luciferase Assay System from Prom-
ega and a Wallac 1420 multilabel counter. To determine the trans-
fection e⁄ciency, part of the lysates were analyzed for L-galactosidase
activity.
3. Results
3.1. Functional characterization of B2 receptor mutants in
293T cells
To investigate the role of phosphorylation and/or internal-
ization of GKq-coupled receptors for MAP kinase activation,
we used the following bradykinin B2 receptor mutants:
B2tI334 with a C-terminal truncation after isoleucine at posi-
tion 334 and a B2vST in which ¢ve serine and threonine
residues within the carboxy-terminal domain were mutated
to alanine. These mutant receptors are signi¢cantly impaired
in their internalization capacity in COS-7 and CHO cells [21].
In this study, we employed HEK 239T cells since they do not
express any endogenous kinin receptor (unlike COS-7 cells),
they can be transiently transfected with high yields and they
are a well-established cell model to study mitogenic signalling
pathways [5,25].
Initially, we tested the functionality of the wild-type and
mutant B2R in transiently transfected 293T cells by measuring
their coupling to phospholipase C and to the receptor phos-
phorylation and internalization machinery. Phospholipase C
activation was studied by following bradykinin-induced gen-
eration of inositol phosphates [22]. Both B2R mutants used in
this study were able to stimulate phospholipase C activity to a
similar extent as wild-type receptor, re£ected by a 3^4-fold
increase in the cellular level of inositol phosphates after
5 min of stimulation with 1 WM bradykinin (Fig. 1A).
We next analyzed the agonist-induced phosphorylation of
B2R variants in 293T cells. Following [32P] labelling of tran-
siently transfected 293T cells and immunoprecipitation of
B2R, receptor phosphorylation was visualized by autoradiog-
raphy [23,24]. B2R in 293T cells showed a weak basal phos-
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phorylation which increased 2^4-fold after 5 min of stimula-
tion with 1 WM bradykinin (Fig. 1B). In contrast, the B2vST
and B2tI334 mutants failed to undergo any detectable agonist-
induced phosphorylation (Fig. 1B). Comparable levels of ex-
pression and immunoprecipitated receptor proteins were con-
¢rmed by parallel binding and [35S] labelling experiments
(data not shown).
We then measured B2R internalization in 293T cells closely
following the kinetics of bradykinin-induced MAP kinase ac-
tivation (see below). Transiently transfected 293T cells were
incubated with 2 nM [3H]bradykinin at 37‡C for 15 min and
surface-bound versus intracellular ligand was determined.
Under these experimental conditions, 54 þ 3% of the radioac-
tive bradykinin speci¢cally bound to the wild-type B2R was
found intracellular in 293T cells. The B2vST as well as the
B2tI334 mutant were markedly impaired in their ability to
undergo ligand-induced internalization re£ected by a 3^4-
fold reduction of intracellular localized B2R (Fig. 1C). Cells
transfected with empty expression vector (mock) had no spe-
ci¢c [3H]bradykinin binding and failed to respond to stimula-
tion with 1 WM bradykinin in all three assays presented in Fig.
1.
3.2. Time- and dose-dependent activation of ERK2 in
293T cells by B2 receptors
To characterize bradykinin-inducible MAP kinase activa-
tion, 293T cells were co-transfected with B2R and HA-tagged
ERK2 and stimulated with the indicated bradykinin concen-
trations for varying time periods. HA-ERK2 was immunopre-
cipitated from lysates and ERK2 kinase activity was deter-
mined by an in vitro MBP phosphorylation assay. The
precipitation e⁄ciency was controlled by immunoblotting
with an ERK2 antibody. B2R-mediated ERK2 activation dis-
played typical transient monophasic kinetics, with a peak in
response after 5 min followed by a slow decrease over 60 min
(Fig. 2A) and return to baseline at 120 min (not shown).
Quantitative analysis of incorporated [32P] revealed a 30^40-
fold increase in ERK2 activity after 5 min of bradykinin stim-
ulation. There was no increase in ERK2 kinase activity in cells
stimulated with bradykinin when B2R cDNA was omitted
from the transfection mixtures consistent with the absence
of endogenous receptors in 293T cells. MAP kinase activation
was dependent on the dose of bradykinin applied, with an
apparent EC50 of about 5 nM (Fig. 2B). Immunoblotting
with ERK2 antibodies con¢rmed an equal precipitation e⁄-
ciency for HA-ERK2 throughout the experiments (Fig. 2,
lower panels). Both the kinetics and dose-dependency of bra-
dykinin-induced ERK2 activation is similar in PC12 and HF-
15 cells expressing endogenous B2R (data not shown). Thus,
Fig. 1. Phospholipase C activation, bradykinin-induced phosphoryla-
tion and internalization of B2R mutants. HEK 293T cells were tran-
siently transfected with wild-type B2R, B2vST or B2tI334 or empty
plasmid (mock). A: Increase of total inositol phosphates (IPn) was
measured without (white bars) and with 5 min of 1 WM bradykinin
stimulation (gray bars). Means þ S.D. from ¢ve independent experi-
ments are presented. B: Receptor phosphorylation was determined
after 6 h of [32P] labelling with 0.5 mCi/ml orthophosphate. Cells
were lysed and B2R was immunoprecipitated using polyclonal anti-
bodies against the C-terminal domain (for wild-type and B2vST) or
to the N-terminal and third extracellular domain (B2tI334). Precipi-
tated proteins were separated by 10% SDS-PAGE and [32P] incorpo-
ration was visualized by autoradiography. C: Receptor internaliza-
tion was monitored by incubation of cells with 2 nM
[3H]bradykinin for 15 min. Following removal of extracellular ra-
dioactivity by a low pH wash [22], internalized ligand-receptor com-
plexes were measured after cell lysis using a L-counter. Data are
means þ S.D. of three experiments.
Fig. 2. Time- and dose-dependent ERK2 activation by B2R in 293T
cells. HEK 293T cells grown on six well plates were co-transfected
with B2R and HA-tagged ERK2. Following 24 h of serum starva-
tion, cells were stimulated with 1 WM bradykinin for 1^60 min (A)
or with 0.1 nM to 10 WM bradykinin for 5 min (B). ERK2 activity
was determined after immunoprecipitation of the kinase with a
polyclonal anti-HA antibody and using MBP as a substrate. Reac-
tions were carried out for 20 min at room temperature. Western
blots with a polyclonal ERK2 antibody were performed to con¢rm
that equal amounts of ERK2 were present in the precipitates (lower
panels) and phosphorylated MBP was detected by autoradiography.
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transfected bradykinin receptors are functionally coupled to
the ERK/MAP kinase pathway in 293T cells.
3.3. ERK2 activation and Elk1-driven transcription induced by
B2 receptor are independent of receptor phosphorylation
and internalization in 293T cells
To test whether receptor phosphorylation and internaliza-
tion are necessary for B2R-induced MAP kinase stimulation
and Elk1 transcriptional activation, we analyzed ERK2 kinase
and Elk1 luciferase activity in 293T cells transfected with the
wild-type or mutant B2R. Stimulation of the B2vST, which is
phosphorylation-incompetent and shows a reduced internal-
ization capacity, resulted in an ERK2 activation comparable
to the parental B2R (Fig. 3A). Similarly, challenge of trun-
cated B2tI334 receptors defective in ligand-induced phospho-
rylation and internalization led to a full ERK2 activation
(Fig. 3A). For control, the levels of HA-ERK2 in the im-
munoprecipitates were analyzed by Western blotting using
an antibody against ERK2 (Fig. 3A, center panel).
It has previously been shown that MAP kinase activation
leads to phosphorylation of transcription factors of the Elk
family and to an increase in their transcriptional activity [26].
We therefore studied long-term e¡ects of bradykinin-induced
MAP kinase activation by monitoring Elk1 transcriptional
activation using a luciferase reporter assay. Robust Elk1 acti-
vation was observed when control cells were treated with 10%
FBS/1 WM phorbol-12-myristate-13-acetate (PMA), a mixture
known to strongly activate the MAP kinase cascade (Fig. 3B).
Bradykinin stimulation of B2R for 12 h led to a 12-fold in-
crease in the Elk1-driven luciferase activity. Agonist challenge
of truncated B2tI334 receptors or B2vST mutants increased
the Elk1 transcriptional activity to a comparable level as the
parental B2R (Fig. 3B). Taken together, these results suggest
that both short- and long-term e¡ects induced by MAP kinase
activation are independent on GKq protein-coupled B2R phos-
phorylation and internalization.
4. Discussion
Several intracellular pathways which link GPCRs with the
activation of the Ras/MAP kinase cascade have been de-
scribed, including activation of protein kinase C, increase in
intracellular calcium, activation of PI3 kinase Q and both re-
ceptor and non-receptor tyrosine kinases as well as transloca-
tion of the Grb2/Sos complex [4,6,7,9]. More recently, it was
suggested that receptor phosphorylation on serine/threonine
residues and internalization play also an important role in
modulating the MAP kinase activity by the L2-adrenergic re-
ceptor [10^12,14]. L2-adrenergic receptor internalization ap-
pears to be necessary for the assembly of signalling proteins
involved in the MAP kinase activation [10,14], pointing to a
novel mechanism by which GPCRs may be linked to mito-
genic signalling machinery.
In this study, we examined whether the GKq-coupled bra-
dykinin B2 receptor utilizes a similar phosphorylation- and
internalization-dependent mechanism to activate the Ras/
MAP kinase pathway. Bradykinin-induced MAP kinase acti-
vation appears to be a fast and monophasic process (Fig. 2).
Similarly, B2R phosphorylation occurs within minutes of ex-
posure to ligand [23] and therefore, it could be involved in
regulation of the MAP kinase pathway. However, the B2R
mutants B2vST and B2tI334 which are completely impaired
in phosphorylation are still fully functional in coupling to the
MAP kinase pathway and phospholipase C signalling (Figs. 1
and 2). Given the fact that the acute MAP kinase activation
induced by bradykinin in in vitro kinase assays (maximum at
5 min) signi¢cantly precedes B2R internalization (maximum at
about 60 min), we have also tested the long-term e¡ects of
MAP kinase activation by monitoring Elk1 transcriptional
activity in the nucleus. The wild-type and mutant B2Rs acti-
vated Elk1 to the similar extent after 12 h stimulation indicat-
ing that the capacity to induce Elk transcriptional activity was
independent of phosphorylation-mediated internalization of
B2R.
We have previously shown that B2R phosphorylation oc-
curs in the carboxy-terminal tail and that this phosphoryla-
tion is required for full agonist-induced internalization [21,23].
Agonist-induced phosphorylation was shown to be causally
linked to internalization for several GPCRs, including the
L2-adrenergic [27] and the m2-muscarinic acetylcholine recep-
tor [28]. Phosphorylated GPCRs can bind arrestin which in
turn targets receptors to clathrin coated pits and subsequent
endocytosis [29]. A recent study revealed a new function of
L-arrestin, it can act as an adapter protein, recruiting acti-
Fig. 3. Bradykinin-induced ERK2 and Elk1 activation by B2R and
mutants. A: HEK 293T cells were co-transfected with empty plas-
mid (mock), wild-type B2R, B2vST or B2tI334 and HA-tagged
ERK2. After 5 min of 1 WM bradykinin stimulation, ERK2 activ-
ities (upper panel) and kinase levels (center panel) were analyzed.
Substrate phosphorylations with (gray bars) or without (white bars)
agonist stimulation were quanti¢ed using a phosphoimager (lower
panel). Means þ S.D. of three independent experiments are shown.
B: For Elk1 activation, a reporter gene assay was used. Luciferase
activities in cells stimulated with 1 WM bradykinin for 12 h (gray
bars) were measured and compared with background levels (white
bars). For control, mock-transfected cells were stimulated with 10%
FBS and 1 WM PMA. Data þ S.D. were calculated from six inde-
pendent experiments.
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vated Src to the agonist-occupied L2-adrenergic receptor and
thereby initiating the MAP kinase cascade [10]. In PC12 cells,
bradykinin-induced complex formation between Pyk2 and Src
leads to Src activation [7], suggesting that B2R might use
other mechanisms than arrestin-mediated internalization to
activate Src and subsequently the MAP kinase cascade in
293T cells. This is consistent with our observations that phos-
phorylation- and internalization-impaired mutants of B2R are
fully capable of activating MAP kinase. It appears therefore
that di¡erent GPCRs such as L2-adrenergic or bradykinin B2
receptors might employ internalization-dependent or -inde-
pendent pathways to activate MAP kinase, respectively.
Taken together, our data show that receptor phosphoryla-
tion and phosphorylation-mediated internalization are not re-
quired for bradykinin-induced MAP kinase activation and
Elk1 transcriptional control in 293T cells. Additional studies
with other types of GPCRs are needed to further explore
whether phosphorylation and internalization play a more
common role in regulation of the MAP kinase pathway by
di¡erent GPCRs.
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